---
title: "iBio receives Nasdaq notice for trading below $1.00 minimum bid price"
url: "https://aibio.space/news/ibio-receives-nasdaq-notice-trading-below-1-00-minimum-bid-price/"
publisher: "aibio.space (Biotech Investor Relations News)"
date: "2025-08-01"
section: "Listings"
tickers: "NASDAQ:IBIO"
source: "https://www.sec.gov/Archives/edgar/data/1420720/000155837025009992/ibio-20250729x8k.htm"
summary: "The company has until January 26, 2026 to regain compliance. Its shares keep trading on The Nasdaq Capital Market under the symbol IBIO for now."
---

By the aibio.space news desk.

Sources

- [iBio, Inc. 8-K (2025-08-01)](https://www.sec.gov/Archives/edgar/data/1420720/000155837025009992/ibio-20250729x8k.htm)

[IBIO](https://aibio.space/companies/ibio/)

2025-08-01

# iBio receives Nasdaq notice for trading below $1.00 minimum bid price

Tickers [IBIO](https://aibio.space/companies/ibio/)

The company has until January 26, 2026 to regain compliance. Its shares keep trading on The Nasdaq Capital Market under the symbol IBIO for now.

## Key facts

- **Company**: iBio, Inc. (NASDAQ: IBIO)

- **News type**: Listings

- **Primary source**: [iBio, Inc. 8-K (2025-08-01)](https://www.sec.gov/Archives/edgar/data/1420720/000155837025009992/ibio-20250729x8k.htm)

*A supreme court building with lit columns. CC0, via rawpixel. The picture shows the field, not the companies named.*

iBio, Inc. said Nasdaq has notified it that its share price has fallen below the exchange's minimum.

On July 29, 2025, the San Diego company received written notice from the Listing Qualifications Department of The Nasdaq Stock Market LLC. The notice said that for the preceding 30 consecutive business days, from June 13, 2025 to July 28, 2025, iBio's common stock did not maintain a minimum closing bid price of $1.00 per share, as Nasdaq Listing Rule 5550(a)(2) requires, according to a [Form 8-K filing](https://www.sec.gov/Archives/edgar/data/1420720/000155837025009992/ibio-20250729x8k.htm).

The notice has no immediate effect on the listing or trading of the shares. Under Listing Rule 5810(c)(3)(A), iBio has a compliance period of 180 calendar days, or until January 26, 2026. It can regain compliance if the closing bid price is at or above $1.00 for a minimum of 10 consecutive business days during that period. Nasdaq may, in its discretion, require a longer run, generally no more than 20 consecutive business days.

If iBio misses the January 26, 2026 deadline, it may be eligible for another 180 calendar days. To qualify, it must meet the other listing standards for The Nasdaq Capital Market and tell Nasdaq it intends to cure the deficiency, by effecting a reverse stock split if necessary.

iBio said it intends to actively monitor its bid price and will consider available options, including a reverse stock split, if necessary, to maintain its Nasdaq listing.

[Report an error](https://aibio.space/reputation/#correction)

## Companies in this story

IBIO

iBio, Inc.

NASDAQ · United States

Open the starter desk

## More in Listings

Listings

### [Propanc Biopharma faces Nasdaq delisting on bid price, plans to appeal](https://aibio.space/news/propanc-biopharma-faces-nasdaq-delisting-bid-price-plans-appeal/)

Oct 29, 2026

Listings

### [Reviva asks stockholders to approve reverse split of up to 1-for-100](https://aibio.space/news/reviva-asks-stockholders-approve-reverse-split-up-1-100/)

Oct 29, 2026

Listings

### [Nasdaq to delist Glucotrack shares after bid price exception ends](https://aibio.space/news/nasdaq-delist-glucotrack-shares-after-bid-price-exception-ends/)

Oct 28, 2026

---
Source page: https://aibio.space/news/ibio-receives-nasdaq-notice-trading-below-1-00-minimum-bid-price/. Facts in aibio.space stories are checked against company filings and releases; opinion is labelled. Cite as: aibio.space, "iBio receives Nasdaq notice for trading below $1.00 minimum bid price", 2025-08-01, https://aibio.space/news/ibio-receives-nasdaq-notice-trading-below-1-00-minimum-bid-price/